The Cell and Gene Therapy (CGT) Catapult, of London, announced a partnership with London-based Freeline Therapeutics Ltd., a company focused on the development of adeno-associated virus-based gene therapies, to further develop the company's manufacturing platform at the CGT Catapult's large-scale GMP manufacturing center in Stevenage, Hertfordshire, U.K.